New technologies have produced a revolution in primary varicose vein treatments. Duplex ultrasound is now used for preoperative diagnosis, postoperative surveillance, and during many procedures. Ultrasound has also altered our understanding of the pathophysiology of chronic venous disease. Laser and radiofrequency saphenous ablations are common. Classic techniques, such as sclerotherapy, high ligation, stripping, and phlebectomy, have been improved. Magnetic resonance venography, computed tomographic venography, and intravascular ultrasound have improved diagnostic capabilities. New strategies like ambulatory selective varices ablation under local anesthesia (ASVAL) and conservative hemodynamic treatment for chronic venous insufficiency (CHIVA) raise important questions about how to manage these patients. Semin Vasc Surg 25:18-24
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RIMARY VARICOSE VEIN management has undergone a revolution based on technological advances. Duplex ultrasound has impacted almost every facet of phlebology, including preoperative diagnosis, periprocedural monitoring, postoperative surveillance, and even our understanding of the disease process itself. Thermal (laser or radiofrequency) and chemical (sclerotherapy) ablation techniques now far outnumber the surgical procedures of high ligation, stripping, or phlebectomy in the United States. 1 The surgical techniques, however, have evolved as well. Technical advances have also made possible paradigm-challenging advances in our understanding in the natural history of reflux, which have impacted strategies for saphenous, epifascial, and perforator treatment. These technical and intellectual advances have resulted in new certifications with the American Board of Phlebology in 2008 for physicians and Registered Phlebology Sonographer in 2010 for physicians and ultrasonographers.
Ultrasound
Of all the technological changes, the development of venous ultrasound has been the most profound. Ultrasound is now used as the primary diagnostic tool to map the extent of reflux. 2 It is used routinely during saphenous and perforator ablation to ensure accurate ablation. It is also used during chemical ablation of epifascial veins if the epifascial veins are large in diameter or near deep veins to ensure accurate placement of the foamed sclerosant. 3 After these various treatments, it is used to check for technical success (vein occlusion) and adverse events (eg, heat-induced or deep venous thrombosis).
Besides the dramatic increase in use for procedures, ultrasound techniques have been refined. The reflux study is now performed standing to more closely mimic physiological conditions, when gravity actually causes reflux. Saphenous veins are now defined as running in saphenous sheaths (Fig 1) because these veins are hemodynamically different than the epifascial veins with which they can be confused. Consensus opinion defines reflux as retrograde flow Ͼ0.5 seconds (500 ms) in most veins, except 1.0 seconds (1000 ms) in the case of the femoropopliteal system, to account for normal valve closure time. 4 
Ablation Techniques
Thermal ablation has largely replaced surgical high ligation with or without stripping for saphenous veins in the Unites States (Fig 2) . 1 During this procedure, the vein is closed through a process of vein wall and lumen fibrosis. 5 Reabsorption of the vein occurs over several months in many cases. 6 Thermal ablation causes less pain and discomfort and reduces convalescence time compared with surgery. 2 When performed in indicated patients, these procedures are highly technically successful, and improve patient quality of life. 5 Recent consensus opinion recommends thermal ablation preferentially to surgical or chemical ablation for saphenous veins. 2 Thermal ablation has also been used successfully in perforator 2 and saphenous tributary 3 ablation as well.
Radiofrequency ablation and laser ablation have similar efficacy and safety. 2 There has been much debate about the potential importance of laser wavelength, but results seem similar at wavelengths between 810 and 1470 nm. Results depend mostly on energy delivery, good tumescent anesthesia, and proper catheter placement (Fig 3) . The choice of radiofrequency or laser energy, or which specific laser wavelength to use, less effect. 3 Chemical ablation seemed destined for a minor role in phlebology in 1974, when Hobbs found surgery superior to liquid sclerotherapy in a randomized controlled trial. 7 The advent of foamed sclerosants, however, transformed chemical ablation because of its increased efficacy. Foam will fill a vein and remain in place unless there is muscle contraction, increasing time of endothelial contact compared with liquid sclerotherapy, which acts as a jet and has a brief endothelial contact time. Additionally, foam is easily visible with ultrasound guidance (Fig 4) , facilitating accurate ablation and avoidance of deep vein complications. 3 Foam is now commonly used in the treatment of epifascial veins. Foamed sclerosants have also been used with competitive success in treating saphenous veins 8 and perforator veins. 9 Chemical ablation has historically been plagued by wide variation in techniques, resulting in a wide range of reported results. This situation is now changing, and techniques are improving rapidly. The optimum sclerosant, sclerosant gas, sclerosant to gas ratio, safe injection volumes, patient positioning, use of filters to minimize bubble size, among other issues, are still debated. 10 Although endovascular procedure volumes have skyrocketed, surgical procedures have made considerable improvements as well. High ligation with stripping or high ligation alone remain the preferred surgical options for saphenous veins. Most often, high ligation with stripping is performed on the great saphenous vein due to increased efficacy against high ligation alone, and above the knee only to prevent saphenous nerve injury. High ligation alone with a short-length phlebectomy is the usual procedure on the small saphenous vein to prevent sural nerve injury. The procedure is sometimes performed under local anesthesia and with preoperative ultrasound marking. 11 A tourniquet can be applied before the procedure to limit blood loss, bruising, and pain. Perforation/invagination stripping instead of acorn use can also limit surgical trauma. 12 Epifascial veins can be treated with ambulatory phlebectomy, which is often performed under local anesthesia and produces small wounds requiring no sutures and results in only small scars (Fig 5) . 13 Powered phlebectomy, using a machine to macerate the varicosities, can save time in the case of numerous varicosities. 14 Subfascial endoscopic perforator surgery remains a viable option to treat pathologic perforator veins. 15 The initial reported results of the new endovascular techniques of thermal and chemical ablation were surrogate outcomes of ultrasound-based vein closure. Clinical scores have since been developed and are now in reasonably common use. CEAP (Clinical, Etiology, Anatomic, Pathophysiologic) score can be used to describe crosssectional disease severity. 16 The Venous Clinical Severity Score (VCSS) is a newly revised combination of patientreported and physician-reported disease severity useful longitudinally over time, and can be used to track the results of interventions. 17 Technology has permitted better diagnosis as well. With the improvement in diagnostic techniques, such as intravascular ultrasound, magnetic resonance venography, and computed tomographic venography, some patients assumed to have primary venous disease are now found to have deep vein issues, and can be managed more effectively. Intravascular ultrasound is more sensitive than venogram at detecting iliocaval venous obstruction, and patients can be effectively treated upon diagnosis with angioplasty and stenting when diagnosed. 18 Pelvic congestion syndrome often presents with proximal medial thigh varicosities, even though the reflux begins in the suprainguinal region, usually the ovarian vein. Ultrasound, magnetic resonance venography, computed tomographic venography, and conventional venography are diagnostic tools to detect pelvic congestion syndrome. 2 
New Treatment Strategies
In addition to its direct clinical applications, duplex ultrasound has played a key role in understanding the natural history of reflux. In the 19 th century, Rima (1836) hypothesized and then Trendelenburg (1890) popularized the idea that reflux progresses from saphenofemoral junction distally down the great saphenous vein over time, defining the saphenous vein as the main treatment target in primary varicose veins. 19 A similar process could explain the saphenopopliteal junction and small saphenous vein. Both longitudinal 20 and cross-sectional 21, 22 ultrasound studies now show that reflux can in fact spread proximally over time, and that this process is actually quite common.
If reflux progresses in an anterograde fashion, and reflux can spread from epifascial to saphenous veins, then perhaps treatment of the epifascial veins while the saphenous vein is spared would be effective. Pittaluga and colleagues have presented a retrospective cohort of patients treated with this strategy, called ASVAL (ambulatory selective varices ablation under local anesthesia). Physician judgment is used to decide whether to treat the epifascial veins only, or to also treat the saphenous vein. Patients with primary varicose veins or less severe disease (eg, lower CEAP class or less severe symptoms) have done very well in retrospective analysis of the cohort of patients treated with AS-VAL. 23 Importantly, ASVAL treatments result in correction of saphenous reflux with epifascial treatment only in a significant number of patients. 23 Correction of saphenous reflux with epifascial treatment only was also shown using a different strategy in patients with saphenofemoral junction reflux and incompetent varicose tributaries, but a competent saphenous terminal valve. 24 These studies raise the possibility that early correction of epifascial reflux before it spreads up the saphenous vein to the terminal valve might, in fact, reverse the disease and prevent the need to treat the saphenous vein at all in many cases.
There has been significant debate over whether concomitant or staged treatments of saphenous and epifascial veins are preferable when both are involved in disease. Not coincidentally, those preferring phlebectomy for epifascial vein management often recommend a concomitant saphenous and epifascial treatment, while those preferring sclerotherapy often recommend a staged management. Concomitant treatments are convenient for the patient and can result in faster symptomatic improvement, 25 probably due to the faster removal of refluxing veins. Staged treatments allow epifascial varicosities to become smaller and easier to treat with sclerotherapy. 3 Some varicosities disappear after saphenous treatment, thereby preventing unnecessary treatments. 26 Perforator vein treatment is a controversial issue. Incompetent perforator veins (IPV) are associated with worse clinical disease based on CEAP class. 27 Treatment of IPVs, however, has not been shown to improve clinical outcomes independent of saphenous vein treatment. 28 Treatment of IPVs in addition to refluxing saphenous veins did not result in clinical improvement in CEAP class C2 patients compared to saphenous treatment alone. 29 Additionally, treatment of the saphenous vein results in correction of perforator incompetence in many patients with a competent deep system. 30 Ultrasound and a hemodynamic understanding of IPVs can be helpful. Distal IPVs in the setting of a refluxing saphenous vein likely represent the kind of re-entry perforator analyzed by Bjordal in the 1970s. 31 Current consensus opinion is to treat IPVs only when the IPV is near an active or healed ulcer, essentially the "ankle blow-out" pathophysiology articulated by Cockett and Jones back in the 1950s. 32 Such a strategy leaves out potentially effective treatments for a patient with a proximal IPV acting like an incompetent saphenofemoral junction, or "perforator junction" (Fig 6) .
Despite the dramatic improvements in treatment, there is still no cure for primary varicose veins. Recurrence remains a problem. Many of the risk factors for varicose veins, such as aging, genetics, number of pregnancies, and standing occupation, remain difficult or impossible to modify. There is some evidence that leaving a draining deep-saphenous junction (eg, saphenofemoral junction), as is routine in endovascular saphenous ablation, actually reduces the deep-saphenous junction neovascularization, which has plagued high ligation with or without stripping. 33 The saphenous stripping technique has actually been tested with junctional sparing, similar to the procedure in endovascular ablation, with good results. 34 There are now two randomized controlled trials using CHIVA (in French, cure conservatrice et hemodyamique de l'insuffisance veineuse en ambulatoire [conservative hemodynamic treatment for chronic venous insufficiency]), showing a reduction in recurrent varicosities at 5-to 10-year follow-up. 35, 36 In CHIVA, primary varicose vein patients are treated with surgical ligations performed at preoperatively selected points where reflux crosses from deep to saphenous, deep to epifascial, or saphenous to epifascial compartments based on a hemodynamic model. 37 Interestingly, the reflux remaining after the CHIVA procedure does cause recurrence. The reduced risk of recurrence from remaining and draining veins, however, more than compensates for the remaining reflux. 35 Perhaps the combination of short-segment saphenous thermal ablation (using a perforator-like ablation technique) with the CHIVA strategy would cause even less recurrence than either approach alone. The CHIVA results also suggest that there might be a tradeoff between the patient's symptomatic improvement from the ablation of reflux (or at least its disconnection, as in CHIVA), and the increased risk of later recurrence from overly aggressive reflux ablation, which can eliminate drainage pathways.
Conclusions
The specialty of phlebology has evolved rapidly, made possible mostly due to better technology. The development of duplex ultrasound has been like the invention of the microscope or telescope in biology or physics, allowing us to see better to monitor venous disease noninvasively in clinical and research uses. Ultrasound is now used preoperatively, intraoperatively, and postoperatively. The endovascular venous ablation techniques of thermal or chemical ablation are safe, effective, and common. Surgical techniques have also made substantial progress. The imaging techniques of intravascular ultrasound, magnetic resonance venography, and computed tomographic venography now allow us to diagnose venous conditions often missed in the past, such as iliocaval obstruction and pelvic congestion syndrome. Duplex ultrasound has also changed our understanding of the pathophysiology of primary varicose vein disease. Ongoing research suggests that some patients can benefit from epifascial treatment alone, even in the presence of saphenous re- 
